O financiamento dos medicamentos nos municípios do Brasil

De quem é a responsabilidade

Bibliographic Data

ID16780341
AuthorsSilvana Nair Leite (0000-0002-5258-9684, Universidade de Brasília), Rodrigo Fonseca Lima (0000-0001-8173-4425, Universidade de Brasília), Wendell Rodrigues Oliveira da Silva (0000-0002-7967-9962, Universidade de Brasília), Ivanessa Thaiane do Nascimento Cavalcanti (0000-0002-4925-6301, Universidade de Brasília), Rosângela Santos Santana (0000-0003-4481-210X, Universidade de Brasília)
Year2024
Volume58
Issue1
Pages48
Publication date2024-11-08
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueRevista de Saúde Pública (JOURNAL)
Journal identifiersISSN: 0034-8910 • E-ISSN: 0034-8910
PublisherUniversidade de São Paulo. Agência de Bibliotecas e Coleções Digitais (PUBLISHER)
DOI10.11606/s1518-8787.2024057005565
PMID39607211
OpenAlexW4404836812
LanguagePT
Citations received7
References cited10

OBJECTIVE: To analyze the investments made in medicines by the federated entities and the asymmetries in these investments from 2016 to 2020, which may have an impact on the supply of and access to these medicines in the SUS. METHODS: This is an exploratory, retrospective study to identify who are the main entities responsible for investment in Primary Care medicines in municipalities, the evolution, counterparts, and regional differences of this investment between 2016 and 2020. RESULTS: The amounts spent on medicines by Brazilian municipalities were higher than the contribution to the CBAF from the MS or the MS + State in all the years analyzed. The average percentages of federal funds transferred and municipal spending varied according to the region of Brazil. The average per capita amount invested in medicines by municipalities increased between 2016 and 2020 (deflation applied), with a greater impact for municipalities with lower MHDI. The Farmácia Popular program mainly reaches municipalities with the largest populations and the highest MHDI and is therefore not enough to address the inequalities in access pointed out. CONCLUSIONS: There has been a widening of inequalities in the capacity of municipalities to ensure access to medicines, especially among the most vulnerable municipalities, accumulating even more risks of illnesses and deaths from primary care-sensitive diseases

Political science · Healthcare Regulation · Pharmaceutical Economics and Policy · Public Health in Brazil

Tools

Open DOIOpen Access